bpc-157 unapproved drug fda statement advisers weigh relaxing rules on three more peptides to widen access FDA's Overreach on Compounded Peptides

FDA's Overreach on Compounded Peptides An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with Health advisers begin meeting Thursday to review more than a half dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective. Full story FDA advisers back first four of seven unapproved peptides under review for looser rules Reuters The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT

SKU: 9261185859 · From ldesquadrias.com.br